CDRH 483s Will Include Language Developed Under GMP Initiative
This article was originally published in The Gray Sheet
Executive Summary
FDA is seeking to reconcile device Form 483s with new language being added to drug inspection documents under the auspices of CDER's GMP initiative, according to FDA Assistant Commissioner of Regulatory Affairs Steve Niedelman